BIOATLA, INC. Diluted Shares Outstanding (Weighted Average)
BIOATLA, INC. (BCAB) reported Diluted Shares Outstanding (Weighted Average) of 1.66 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- BIOATLA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.66M shares, a 42.02% increase year-over-year.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.50M shares, a 28.90% increase year-over-year.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 59.81M shares, a 20.45% increase year-over-year.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 58.75M shares, a 21.54% increase year-over-year.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 58.83M shares, a 21.11% increase from fiscal 2024.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 48.57M shares, a 1.67% increase from fiscal 2023.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 47.78M shares, a 22.74% increase from fiscal 2022.
- BIOATLA, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 38.93M shares, a 12.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.66M shares 10-Q · filed 2026-08-13 | 1.58M shares 10-Q · filed 2026-08-13 | 20.99M shares derived: average of 3 quarters · filed 2026-08-13 | 30.43M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | 1.50M shares 10-Q · filed 2026-05-15 | 30.65M shares derived: average of 2 quarters · filed 2026-05-15 | 40.02M shares derived: average of 3 quarters · filed 2026-05-15 | 30.31M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | 59.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 59.28M shares derived: average of 2 quarters · filed 2026-03-31 | 39.91M shares derived: average of 3 quarters · filed 2026-08-13 | 58.83M shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 58.75M shares 10-Q · filed 2025-11-13 | 29.96M shares derived: average of 2 quarters · filed 2026-08-13 | 58.50M shares 10-Q · filed 2025-11-13 | 27.68M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | 1.17M shares 10-Q · filed 2026-08-13 | 58.50M shares 10-Q · filed 2025-08-07 | 1.17M shares 10-Q · filed 2026-08-13 | 58.38M shares 10-Q · filed 2025-08-07 | 17.33M shares derived: average of 3 quarters · filed 2026-08-13 | 25.08M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 1.16M shares 10-Q · filed 2026-05-15 | 58.25M shares 10-Q · filed 2025-05-06 | 25.41M shares derived: average of 2 quarters · filed 2026-05-15 | 33.05M shares derived: average of 3 quarters · filed 2026-05-15 | 36.84M shares derived: average of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | 49.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 48.99M shares derived: average of 2 quarters · filed 2026-03-31 | 48.73M shares derived: average of 3 quarters · filed 2026-03-31 | 48.57M shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | 48.34M shares 10-Q · filed 2025-11-13 | 48.28M shares derived: average of 2 quarters · filed 2025-11-13 | 48.21M shares 10-Q · filed 2025-11-13 | 48.16M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 48.21M shares 10-Q · filed 2025-08-07 | 48.15M shares 10-Q · filed 2025-08-07 | 48.10M shares derived: average of 3 quarters · filed 2025-08-07 | 48.03M shares derived: average of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | 48.09M shares 10-Q · filed 2025-05-06 | 48.04M shares derived: average of 2 quarters · filed 2025-05-06 | 47.97M shares derived: average of 3 quarters · filed 2025-05-06 | 47.90M shares derived: average of 4 quarters · filed 2025-05-06 | ||
| 2023-12-31 | 47.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 47.91M shares derived: average of 2 quarters · filed 2025-03-28 | 47.84M shares derived: average of 3 quarters · filed 2025-03-28 | 47.78M shares 10-K · filed 2025-03-28 | ||
| 2023-09-30 | 47.83M shares 10-Q · filed 2024-11-07 | 47.77M shares derived: average of 2 quarters · filed 2024-11-07 | 47.71M shares 10-Q · filed 2024-11-07 | 46.64M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 47.71M shares 10-Q · filed 2024-08-08 | 47.64M shares 10-Q · filed 2024-08-08 | 46.24M shares derived: average of 3 quarters · filed 2024-08-08 | 44.06M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 47.58M shares 10-Q · filed 2024-05-14 | 45.51M shares derived: average of 2 quarters · filed 2024-05-14 | 42.85M shares derived: average of 3 quarters · filed 2024-05-14 | 41.49M shares derived: average of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | 43.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 40.48M shares derived: average of 2 quarters · filed 2024-03-26 | 39.46M shares derived: average of 3 quarters · filed 2024-03-26 | 38.93M shares 10-K · filed 2024-03-26 | ||
| 2022-09-30 | 37.52M shares 10-Q · filed 2023-11-07 | 37.47M shares derived: average of 2 quarters · filed 2023-11-07 | 37.42M shares 10-Q · filed 2023-11-07 | 37.31M shares derived: average of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | 37.42M shares 10-Q · filed 2023-08-01 | 37.37M shares 10-Q · filed 2023-08-01 | 37.24M shares derived: average of 3 quarters · filed 2023-08-01 | 36.41M shares derived: average of 4 quarters · filed 2023-08-01 | ||
| 2022-03-31 | 37.32M shares 10-Q · filed 2023-05-11 | 37.16M shares derived: average of 2 quarters · filed 2023-05-11 | 36.07M shares derived: average of 3 quarters · filed 2023-05-11 | 35.48M shares derived: average of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | 36.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 35.45M shares derived: average of 2 quarters · filed 2023-03-23 | 34.86M shares derived: average of 3 quarters · filed 2023-03-23 | 34.56M shares 10-K · filed 2023-03-23 | ||
| 2021-09-30 | 33.91M shares 10-Q · filed 2022-11-04 | 33.79M shares derived: average of 2 quarters · filed 2022-11-04 | 33.75M shares 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | 33.68M shares 10-Q · filed 2022-08-09 | 33.67M shares 10-Q · filed 2022-08-09 | ||||
| 2020-12-31 | 8.43M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |